Discover
LEXX
Lexaria Bioscience Corp.
3.24
2 x 2.45
2 x 3.62
bid
ask
-
0.05
1.52%
2 @ 04:00 PM
3.32 +0.08 (2.47%)
| Ytd | -65.01% | |
| 1y | -82.30% |
3.15
day range
3.52
2.80
52 week range
23.25
| Open | 3.25 | Prev Close | 3.29 | Low | 3.15 | High | 3.52 | Mkt Cap | 6.83M |
| Vol | 76.32K | Avg Vol | 52.88K | EPS | -5.10 | P/E | N/A | Forward P/E | -5.64 |
| Beta | 1.06 | Short Ratio | 2.34 | Inst. Own | 6.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 8.16 | 200-d Avg | 10.34 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 1.99M | ||
| Research and Development Expense | 970.83K | ||
| Selling, General and Administrative Expense | 1.02M | ||
| Operating Income | -1.99M | ||
| Income Tax Expense | 14.00 | ||
| Net Income | -1.99M | ||
| Net Income Common Stock | -1.99M | ||
| Net Income Common Stock (USD) | -1.99M | ||
| Consolidated Income | -1.99M | ||
| Net Income to Non-Controlling Interests | -1.78K | ||
| Earnings per Basic Share | -1.20 | ||
| Earnings per Basic Share (USD) | -1.20 | ||
| Earnings per Diluted Share | -1.20 | ||
| Earning Before Interest & Taxes (EBIT) | -1.99M | ||
| Earning Before Interest & Taxes (USD) | -1.99M | ||
| Weighted Average Shares | 1.65M | ||
| Weighted Average Shares Diluted | 1.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.48M | ||
| Cash and Equivalents (USD) | 3.48M | ||
| Investments | 142.10K | ||
| Investments Current | 142.10K | ||
| Trade and Non-Trade Receivables | 113.01K | ||
| Current Assets | 4.06M | ||
| Property, Plant & Equipment Net | 313.43K | ||
| Total Assets | 4.78M | ||
| Debt Current | 33.03K | ||
| Total Debt | 86.71K | ||
| Current Liabilities | 383.41K | ||
| Debt Non-Current | 53.68K | ||
| Total Liabilities | 437.09K | ||
| Accumulated Retained Earnings (Deficit) | -68.50M | ||
| Accumulated Other Comprehensive Income | -46.47K | ||
| Shareholders Equity | 4.74M | ||
| Shareholders Equity (USD) | 4.74M | ||
| Assets Non-Current | 716.46K | ||
| Total Debt (USD) | 86.71K | ||
| Goodwill and Intangible Assets | 339.02K | ||
| Liabilities Non-Current | 53.68K | ||
| Trade and Non-Trade Payables | 350.38K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 28.48K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.65M | ||
| Net Cash Flow from Investing | -27.09K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -837.00 | ||
| Net Cash Flow from Operations | -1.64M | ||
| Effect of Exchange Rate Changes on Cash | 8.97K | ||
| Share Based Compensation | 92.94K | ||